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There is growing concern (1) that a large
number of man-made chemicals that have
been released into the environment can
disrupt the endocrine systems of animals
and humans. Among the chemicals ofcon-
cern are the persistent, bioaccumulative
organohalogen compounds that include
some pesticides and industrial chemicals
such as polychlorinated aromatics, other
synthetic products, and some metals.
Possible mechanisms bywhich these chem-
icals may interfere with endocrine function
include their ability to mimic natural hor-
mones (both as agonists and antagonists),
including recognition of their specific
binding sites, ability to react directly or
indirectly with hormone structure to alter
it, and ability to alter the pattern of hor-
mone synthesis or modulate hormone
receptor numbers and affinities. The poly-
chlorinated biphenyls (PCBs) are known
or suspected to express biological activities
through most, if not all, of these mecha-
nisms.
PCBs are mixtures of chlorinated aro-
matic chemicals manufactured by chlorina-
tion of biphenyl under suitable conditions
for varying the percentage by weight of
chlorine incorporated. The chemical struc-
ture (Fig. 1) ofPCBs can be represented in
a general way, where n,n' is the number of
chlorine atoms replacing hydrogen atoms in
each ring. A total of209 different congeners
are theoretically possible, but less than half
that number appear to account for nearly all
ofthe environmental contamination attrib-
utable to PCBs. If potential toxicity, envi-
ronmental prevalence, and relative abun-
dance in animal tissues are considered as
criteria, the number of environmentally
threatening congeners decreases to fewer
than 50. Furthermore, fewer than 25 of
these may account for most of the total
PCB burden in tissues ofinvertebrates, fish,
birds, and mammals (2).
PCBs were discovered before the turn
of the century, and their usefulness in
industry as, for example, dielectric and
heat-exchange fluids with desirable physi-
cal properties, was recognized early. Their
chemical resistance and neutral organic
chemical nature have led to widespread
distribution in the environment, including
food webs. Now PCBs are almost entirely
restricted to use in closed systems. Human
exposure to PCBs has resulted largely from
the consumption offood, but occupational
exposure also results from inhalation and
skin absorption. PCBs accumulate in the
fatty tissues ofhumans and other animals.
In turn, PCBs have caused toxic effects in
humans and animals. The skin and liver
are major sites of pathologic change, and
other targets include the gastrointestinal
tract, the immune system, and the nervous
system. Studies in animals suggest that
some PCB congeners may be carcinogenic
and that they can promote the carcino-
genicity of other chemicals. Such toxico-
logical properties, both qualitatively and
quantitatively, often are congener specific
with remarkable dependence on number
and position of chlorine substitutions.
Structural patterns can thus be used to dis-
criminate among PCB congeners on the
basis of toxic potential, if not entirely on
toxicity per se (3,4).
The toxic effects of PCBs appear to
involve at least three types ofbasic mecha-
nisms of action: 1) reversible interaction
(binding) ofthe PCB with specific molecu-
lar sites of action such as receptors,
enzymes, etc., 2) irreversible covalent inter-
action (binding) between the PCB (proba-
bly a reactive metabolite) and target mole-
cules (particularly macromolecules such as
DNA and proteins), and 3) accumulation
ofhighly lipid-soluble, metabolically stable
PCBs in lipid-rich tissues or tissue com-
partments. The same or different structural
properties may be involved in the expres-
sion of these toxic effects. Of particular
interest to this discussion is the use of
Figure 1. General structure for PCBs. o, m, p denote
ortho, meta, and parapositions, respectively.
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structure-activity relationship (SAR)
approaches to study the reversible interac-
tion ofPCB congeners with specific molec-
ular sites in biological systems that normal-
ly control or mediate hormonal activities
in the body. In the study of SARs, the
basic philosophy is to draw conclusions by
analogy, assuming that similarity of PCBs
with respect to certain chemical proper-
ties/reactivities will result in similar biolog-
ical responses (5). Thus, the problem is
one of determining these properties and
how they are linked to specific biological
activities ofinterest.
PCB Chemical Reactivities
Underlying Toxicity
PCB chemical reactivities are encoded with-
in the chemical structure ofthe PCB mole-
cule. Because chemical reactivities underlie
biological activities (6), it is important to
understand how structure determines the
important reactivities and, in turn, how
these reactivities are linked to toxicity. One
ofthe more important applications of SAR
approaches is to help guide mechanistic
research and permit testing of mechanistic
hypotheses (7). Simplifying and classifying
relevant chemical reactivities can be an
important first approach to studying molec-
ular mechanisms oftoxicity.
Stacking Interactions and
CoplanarityofStructure
The importance of coplanarity of PCB
structure (Fig. 2) in producing dioxinlike
toxic effects has been recognized for some
time (8). The chemical reactivity (5) associ-
atedwith this structural feature is the ability
to undergo stacking-type molecular interac-
tions with other planar aromatic ring sys-
tems such as the heme system in hemopro-
teins. Such stacking interactions between
aromatic ring systems have also been
referred to as a charge-transfer or donor-
acceptor interaction and can be viewed in a
simplistic sense as a "Velcro-type" interac-
tion in which the planar rings facilitate the
"sticking together" of the two pieces. It
should be pointed out here that the term
"coplanar" PCB as widely used in this con-
text is a misnomer in the sense that all
PCBs are basically non-coplanar in nature
(8). The important distinguishing property
of the non-ortho-substituted PCBs is that
the increase in the conformational enthalpy
(AH) required for the non-ortho-substituted
biphenyl to achieve a coplanar state is suffi-
ciently offset (outweighed) by the favorable
change in binding free energy (AG) associ-
ated with formation ofa stacking biphenyl-
receptor complex. All ortho-substituted
PCBs are likely to undergo binding interac-
tions in which a coplanar state is never fully
achieved.
Cleft-type Interactions and Lateral
Chlorine Substitution
Lateral (meta, para substitutions) chlorina-
tion (Fig. 2) has also been recognized
(10-12) as an important structural feature
in PCB binding interactions and toxicity.
Halogen atoms like chlorine contain many
electrons and are thus highly polarizable.
Many appropriately placed polarizability
interactions in a protein-binding site can
be quite effective in binding a PCB mole-
cule. The most polarizable chlorines are
those contained in the lateral positions of
the PCB molecule. This can be envisioned
as a molecular cleft-type interaction
between the highly polarizable lateral halo-
gen atoms and the hydrophobic interior of
the cleft provided by amino acid side
chains that converge on the halogen sub-
stituents. Similar binding interactions
could involve chlorines in nonlateral (ortho
substitutions) positions of the molecule,
but there is not clear evidence that such
interactions are important in PCB binding
and toxicity (3). An additional factor asso-
ciated with the polarizable chlorines is
when the number and positions of chlo-
rines are favorable to driving a preferred
polarizability vector in the molecule (8).
This is the case in the coplanar PCBs with
lateral substitutions, where the preferred
orientation is about the longest axis
(through the para, para' positions) of the
molecule. This type of preferred polariz-
ability can facilitate the stacking interac-
tions referred to earlier by strengthening
the charge-transfer interaction or in sim-
ple, nonscientific terms, making it "sticki-
er" (7). Both stacking and polarizability
interactions might also be possible for cer-
tain stable metabolites of PCBs such as
their hydroxylated metabolites.
Areas ofHigh Electron Density and
Oxidative Metabolism
A third type ofstructural feature that may
be important in leading to a different type
ofPCB toxicity is the availability ofvicinal
unsubstituted positions in the molecule
(such as vacant meta, para positions) that
can provide sites for oxidative metabolism
to occur (13). In this case the chemical
reactivity in the molecule that may control
the rate and regiospecificity of oxidative
attack involves areas ofhigh electron densi-
ty such as may occur at opposite ends of
the polarization vector described above.
Because reactive intermediary metabolites
can be formed in such a process, it is possi-
ble that reactive metabolites can lead to
covalently bound residues with biomole-
cules. Stable metabolites can have chemical
reactivity of their own and lead to similar
or different kinds of binding and toxicity
as seen with the parent PCBs (14). Other
types ofmetabolites and metabolic process-
Figure 2. Wire- and space-filled models comparing coplanar (3,3',4,4',5,5'-HCB, upper right) and non-
coplanar (2,2'4,4',6,6'-HCB, upper left) PCBs with a chlorinated diphenyl ether (2,3',4,4',6-CDE, lower left)
and thyroxine (lower right; aligned by planarface of one or more rings; note sterically inaccessible planar
stacking face in 2,2'4,4',6,6'-HCB and similar condition of diphenyl ehter system but with an accessible
planarface). Carbon, green; hydrogen, white; oxygen, red; halogen, magenta.
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Figure 3. Space-filled stacking models comparing coplanar (3,3'4,4',5,5'-, upper left) and non-coplanar
(2,3,4,4',5-, upper right) PCBs with dioxin (lower left) and chlorinated diphenyl ether (2,3',4,4',6-, lower
right) interactions with porphine ring system (note separation distance and planar geometrical extent of
stacking interaction involving planarfaces).
Figure 4. Molecular surface representation of3,3',4,4'5,5'-hexachlorobiphenyl (from docking, red) and thy-
roxine complex (from X-ray, green) with binding domain (blue) of human protein prealbumin [compare
contacts with protein surface and importance of lateral chorines in filling binding pockets of thyroxine;
see Rickenbacher et al. (11)].
es are possible and may be important in
the expression of certain forms of toxicity
such as the reported association ofchronic
respiratory effects with methylsulfone
metabolites ofcertain PCB congeners (3).
Although other structural features and
reactivities ofPCBs are possible, they have
been less studied in an SAR framework.
For example, certain pure phenobarbital
(PB)-type inducing PCBs with ortho sub-
stitutions cause hepatomegaly and exhibit
activity as promoters in short-term bioassays
for carcinogenesis (3). The structural basis
for these activities is not clear, but they may
be more a function ofspecific substructural
features than overall PCB structure consis-
tent with the many diverse structures
known to act as PB-type inducers.
Reactivity Models and
Predictions
StackingModels
In attempting to understand the relation-
ship between PCB structure, chemical
reactivity, and biological activity, theoreti-
cal models for relevant biological activities
based on PCB molecular parameters have
been sought (7). A planar (or energetically
favorable coplanar) aromatic ring system is
the primary structural feature that is found
in all known high-affinity ligands for the
Ah (or dioxin) receptor, which include
both halogenated and nonhalogenated aro-
matic compounds. Several lines ofevidence
(7,15-17) now suggest that an important
molecular property determining receptor
binding and associated responses for these
compounds is electron affinity. The depen-
dence on this property can best be
explained in terms of compound electron
acceptance in a charge-transfer or stacking-
type receptor model. Such a model also
permits one to readily visualize steric hin-
drance to binding, as is the case for the
ortho-substituted PCBs (Fig. 3), and varia-
tions in molecular size (e.g., compare
PCBs with halogenated naphthalenes).
The somewhat flexible but reasonably
coplanar dioxin molecule shows the closest
stacking followed by the non-ortho- and
ortho-substituted PCBs. In general, the
stacking model predicts increased binding
for the class of chlorinated dioxins with
increased chlorination, but this trend has
not been observed in in vitro experimental
binding studies, possibly reflecting solubili-
ty differences. There is evidence (18) for
such a trend in in vivo absorption and tis-
sue distribution studies in the rat. It is
important to realize that a favorable, close
stacking can occur in some aromatic com-
pounds that are not totally coplanar but
have a sterically accessible planar face, as in
certain chlorinated diphenyl ethers (Fig. 2
and 3). This consideration bears directly
on the structural relationship of PCBs to
Environmental Health Perspectives 292Figure 5. Wire- and space-filled models comparing estrogenic PCB analog (4-OH, 2',4',6'-, bottom) with
estradiol (top) (molecules aligned by common phenolic ring).
thyroid hormones, as discussed below.
Other factors can play a role, such as com-
pound solubilities and lipophilicities.
Nevertheless, the receptor binding and
associated biological responses are best
explained in terms ofchanges in stereoelec-
tronic and thermodynamic properties of
ligands. As applied to PCBs, orthosubstitu-
tion plays a major role in effecting changes
in ligand binding (19,20). The relative
binding affinities to the Ah receptor can be
viewed as a measure of the "stacking reac-
tivity," which can be related directly to
dioxin (TCDD) and expressed as dioxin
equivalents (3). This modeling work has
implications in understanding the natural
role and function oftheAh receptor.
Cleft-type Models
Another important structural property in
determining PCB dioxin -like toxicity is the
presence of lateral chlorine substitution in
the molecular structure. However, this is
not always a requirement for high-affinity
binding to the Ah receptor such as found
for certain polynuclear aromatic hydrocar-
bons (PAHs). As discussed above, this
structural requirement for high toxicity sug-
gests the involvement ofother binding sites
with C-shaped molecular cavities or clefts
with viselike properties in the molecular
recognition process. A binding model of
this type that has been extensively studied is
the prealbumin or transthyretin interaction
model. The importance of lateral substitu-
tions in binding both thyroid hormone ana-
logues and PCBs has been well documented
(10,11) (Fig. 4). Interestingly, this binding
interaction model provides another struc-
tural linkage between PCBs and thyroid
hormones. In fact, there is a family ofpreal-
buminlike proteins apparently involved in
regulating thyroid hormone action (21). As
for stacking reactivity and Ah receptor
binding, relative binding affinities to preal-
bumin can be viewed as a measure of the
"lateral chlorine polarizability reactivity,"
which can be related directly to thyroxine
and expressed as thyroxine equivalents.
PCB interactions with this family of pro-
teins have potential biological consequences
as both agonists and antagonists.
Estrogen-Active Analog Model
While the stacking and cleft-type models
have both pointed to a structural relation-
ship of PCBs to thyroid hormones, other
work (22) has suggested a structural rela-
tionship to steroid hormones, particularly
estrogens. The steroidal estrogens are rela-
tively rigid, polycylic molecules with pro-
nounced asymmetry, and their binding to
the estrogen receptor generally reflects a
high degree of stereospecificity. Several
classes of nonsteroidal synthetic estrogens
have been based on phenyl-substituted
hydrocarbons (23) because ofthe structur-
al relationship to the phenolic A ring in
estradiol. Hydroxylated PCBs are often
found as metabolites of the parent PCBs
(13). In this regard, we theorized that cer-
tain hydroxylated PCBs (Fig. 5) that were
also conformationally restricted due to
ortho substitution might be effective in
binding the estrogen receptor. This proved
to be the case in that the most active PCB
analogues where those that combined a
para-hydroxyphenyl ring with some degree
of ortho substitution. However, it is not
clear if there is some unique property of
the hydroxyl group (such as hydrogen
bonding) or if any other similar-sized
group (such as chlorine) could be substi-
tuted. It is possible that increased ortho
chlorines in the PCB structure might also
provide important hydrophobic bulk struc-
ture in binding the estrogen receptor, but
there was not any direct evidence for this.
In additional analysis ofthese data (unpub-
lished results), the solubility/lipophilic
properties of the PCB are also proving to
be important.
Although ortho substitution in PCBs
can significantly lower the dioxinlike toxici-
ty, it can potentially have the opposite effect
on any estrogen-receptor-mediated toxicity.
This PCB active analog modeling approach
to estrogen receptor binding has implica-
tions for understanding any associated toxi-
city. As was suggested for other PCB reac-
tivities and dioxin and thyroxine equiva-
lents, it is possible to express this PCB reac-
tivity in terms ofestradiol equivalents.
Possible Relationships to
Toxic Endpoints
Relationship to Chlorinated
Diphenyl Ethers
As mentioned earlier, the chlorinated
diphenyl ethers (CDEs) are an important
test case for the structural requirements for
dioxin like toxicity for PCBs. CDEs con-
tain two phenyl rings as do PCBs but for
energetic reasons are unlikely to achieve
coplanar states in their binding interac-
tions, even in the absence ofortho substitu-
tion. Any dioxinlike toxicity and associated
Ah receptor binding are more likely to
reflect molecular interactions involving
non-coplanar states, especially with ortho-
chlorine substituents. The main structural
difference in the two classes ofcompounds
is the ether oxygen bridge (C-O-C angle
of 1200) contained in the CDEs. In addi-
tion to serving as structurally related model
compounds for PCBs, the CDEs are also
ofinterest as potential environmental cont-
aminants, such as their association with
used transformer fluid (24). For both
PCBs and CDEs, chlorine substitutions
provide steric constraint that defines the
minimum energy conformation ofthe aro-
matic rings.
However, the effects on overall confor-
mational properties and structure can be
quite different in the context ofhaving an
accessible planar face for a stacking-type
interaction to occur as postulated for the
dioxin-receptor-binding interaction. In the
case ofPCBs, any degree of ortho substitu-
tion substantially raises the energy barrier
to internal rotation about the pivot bond
(25), and it is likely that ortho-PCBs inter-
act with the dioxin receptor in their non-
planar minimum energy conformations
(26). Therefore, to the extent that toxicity
is truly mediated by coplanar conformers,
ortho-PCBs are likely to be relatively non-
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Figure 6. Space-filled model showing the effects of ortho-chlorine substitution in a tri-ortho-substituted
chlorinated diphenyl ether. Note the relationship (in plane or in x-cloud) of chorines to stacking ring (as
in Figure 3).
toxic. Lethality in guinea pigs may be an
example (10) of this because the nearly
isosteric 3,3',4,4',5,5'-hexachlorobiphenyl
is about 1/100 as toxic as dioxin (reflecting
the energy cost to achieve a coplanar state)
and the structurally related 2,3,3',4,4'5,5'-
heptachlorobiphenyl is relatively nontoxic
at significantly larger (>10-fold) doses.
In the case of CDEs, the effects of
orthosubstitution on dioxin-receptor-bind-
ing are likely to have an enhancing effect.
Ortho substituents provide desirable mini-
mum-energy conformations (Fig. 3)
because the rings now approach a mutually
perpendicular relationship with an accessi-
ble planar face for entering into stacking
interactions. An additional enhancing
effect is realized because there is less energy
cost (more favorable binding free energy
from freezing out rotatable bonds)
required to position the more rigid binding
groups. A similar effect of ortho sub-
stituents in hydroxylated PCBs in enhanc-
ing estrogen receptor binding was previ-
ously described (22). Although other bind-
ing modes are possible, they are somewhat
less favored energetically, but in general
also seriously limit the accessibility of the
other phenyl ring system in entering into
other binding interactions such as those
involving lateral substituents.
Recent work (27,28) has shown inter-
esting differences in the structure-activity
relationships for CDEs as compared to
PCBs. The evidence suggests that both
classes ofcompounds can produce dioxin-
like toxic effects mediated by binding to
the dioxin receptor. For example, non-
ortho-but laterally substituted CDEs were
less toxic than their mono-ortho-substitut-
ed analogues, and similar results were also
observed for their enzyme-inducing poten-
cies. Active congeners were also shown to
include CDEs with multiple ortho-substi-
tutions. These results are consistent with
the anticipated enhancing effects of ortho
substitution in CDEs on dioxin receptor
binding through a stacking molecular
mechanism as previously predicted (7).
In addition, an interesting result was
found (28) in certain highly chlorinated
CDEs that contain multiple ortho substitu-
tions, especially in both rings. The poten-
cies were shown to be similar to those
found (27) for the non-ortho- and mono-
ortho-substituted compounds previously
studied. It is apparent that high degrees of
ortho substitution in CDEs do not signifi-
cantly diminish their Ah-receptor-mediat-
ed responses as seen for the PCBs. It is
proposed that in these cases increased con-
formational restriction is brought about by
additional steric interactions between the
ring systems. The favored conformers
would place the adjacent ortho-chlorine in
the plane of the stacking ring (see Figure
3), which could influence the nature ofthe
stacking interaction. Highly chlorinated
diphenyl ethers, especially with high
degrees (three or four ortho-chlorines) of
ortho substitution, would increase the
polarizability and steric rigidity of the sys-
tem, both expected to further enhance a
stacking interaction. It is anticipated that
the stacking ring would be the most highly
substituted ring, although this is not
always clear (e.g., when both rings contain
the same number of chlorines). However,
high degrees of ortho substitution would
not only lead to chlorine atoms positioned
in the stacking plane but also to close
through-space interactions of ortho- chlo-
rine atoms with the face of the adjacent
aromatic ring system (Fig. 6). This latter
effect can be relieved somewhat in the
absence of meta- chlorine substituents that
buttress the adjacent ortho substituent
(29). Both the in-plane and through-space
intramolecular effects would weaken any
intermolecular stacking interaction.
Nevertheless, it is anticipated that the
structure-activity relationships for these
types of molecules would be complex and
difficult to interpret. Ortho substituents in
CDEs can have both qualitatively and
quantitatively different effects on molecu-
lar structure and reactivity as compared to
the effects seen in the PCBs.
The available SAR data on CDEs sup-
port the involvement ofa conformationally
restricted diphenyl system with an accessi-
ble planar face that can participate in
stacking interactions with protein binding
sites. This type of analysis of CDEs and
model for active compounds further sup-
port the proposal (20) for a stacking type
interaction in dioxin receptor binding and
should be helpful in guiding the selection
ofother congeners to test for the ability to
produce dioxinlike toxicity. The potential
toxicity of members of this class ofchlori-
nated aromatic hydrocarbons needs further
attention because hexa- to decachloro-
diphenyl ethers, all of which are likely to
have high degrees of ortho substitution
(wider range of active congeners possible),
have been identified (30) in human adi-
pose samples at concentrations as high as
2000 pg/g, and they are known contami-
nants ofcommercial products such as tech-
nical-grade pentachlorophenol (31). The
close structural relationship ofactive CDEs
to thyroid hormones is also ofconsiderable
interest and compatible with the possible
thyromimetic properties (7 of these com-
pounds. Clearly, in the context of this
stacking model for binding, the non-ortho-
substituted congeners do not take on spe-
cial significance and, other things being
equal, may have reduced activity relative to
their ortho-substituted counterparts.
Preliminary quantitative structure-activity
relationship (QSAR) studies (Waller C,
and McKinney J, unpublished observa-
tions) with the CDEs based on the stack-
ing-model concept look promising in
understanding the dioxin-receptor-mediat-
ed responses ofthese chemicals. In a recent
teratogenicity study (32) with nine CDEs
in mice, 2,2',4,5,6'-penta- and 2,3',4',6-
tetrachlorodiphenyl ether resulted in the
loss of litters at relatively low doses. Both
ofthese CDEs contain one di-ortho-substi-
tuted ring, and the other has lateral (meta,
para) substituents, but they are not fully
ortho substituted to maximize the steric
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interactions shown in Figure 6. These
results appear to be consistent with the
structural requirements ofactive congeners
predicted by our models.
Relationship to Thyroid Hormones
What emerges from such analysis of SAR
results is that these structurally related
compounds (PCBs and CDEs) can partici-
pate in similar molecular recognition
processes in their potential interactions
with specific molecular sites in biological
systems in which the nature, accessibility,
and polarizability of planar (or coplanar)
face interactions can vary. The obvious
next step in this type ofanalysis is to com-
pare these molecular recognition processes
with those that have been well documented
(33,34) for thyroid hormone analogues as
natural halogenated diphenyl ether systems
ofconsiderable biological importance. The
SAR literature for thyroid-hormone-bind-
ing proteins points to two basic types of
binding proteins: those that bind 3,5,3'-
triiodo-L-thyronine (T3) in preference to
L-thyroxine (T4) and those that bind T4 in
preference to T3. Interestingly, the SARs
for the T3 binding proteins seem to
depend more on the structural properties
of the inner (tyrosyl) ring, whereas the
SARs for the T4 binding proteins depend
more on the outer (phenolic) ring proper-
ties (Fig. 2). In this regard, it is interesting
to note that the nuclear receptors for thy-
roid hormones show considerable depen-
dence of binding on a sterically con-
strained inner ring brought about by the
3,5- (ortho) substituents. We have further
shown (29) that these results can be rea-
sonably explained using a donor-acceptor
or stacking aromatic ring model as previ-
ously described. In this model framework
it is not surprising that biphenyl thyroid
hormone analogues (which lack an ether
oxygen bridge) are inactive (33) because
they basically represent worse-case ortho-
substituted PCBs. Binding ligands for the
triiodothyronine (T3) nuclear receptor and
the dioxin receptor may share common
molecular recognition factors in the expres-
sion oftheir binding activities.
In contrast, the lateral arrangement of
the ortho-diiodophenolic structure in the
outer ring of thyroid hormones is an
important feature characterizing the bind-
ing of all three major transport proteins
(globulin, prealbumin, and albumin), and
is the sole major binding feature for albu-
min. In fact, the T4 binding proteins
appeared to be ideally suited to bind lateral
substituted chlorinated aromatic com-
pounds such as the lateral (meta,para) sub-
stituted PCBs. Molecular modeling and
experimental studies (10,11) now provide
considerable support for this hypothesis.
The best binders (four- to eightfold better
than T4) have only lateral chlorine sub-
stituents, and additional ortho-chlorines do
not lower binding much (two- to threefold
better than T4). One lateral chlorine (as in
the 2,4,6-pattern) is sufficient for apprecia-
ble (about halfT4) binding activity. When
no chlorines (biphenyl) or all (2,2',6,6')
ortho positions are filled, the compounds
show no binding activity. As persistence in
the environment and in biological tissues
usually equates to a high degree of lateral
substitution, it is anticipated that most, if
not all, PCB residues found in human tis-
sues are likely to effectively bind this fami-
ly ofproteins. It is also known (10,11,35)
that hydroxy PCBs can bind this family of
proteins, which suggests that certain PCB
hydroxylated metabolites could produce
the same or similar responses associated
with binding. Similar SAR results (11)
were shown for a T4 nuclear-binding pro-
tein (12) and the microsomal deiodinase
(36) in liver tissue. Other proteins that
may give similar results include tyrosine
hydroxylase and the dopamine receptor.
An important consideration here is that
orthochlorination in PCBs does not signif-
icantly affect this binding activity. One
indirect effect ofortho substitution on this
binding activity may be to effectively
inhibit binding to the T3 family ofbinding
proteins that presumably require a stacking
interaction. Therefore, any biological
responses associated with this "laterality"
type ofbinding activity (as in the prealbu-
min interaction model) could be elicited
by a much larger number of PCB con-
geners of environmental concern because
most are ortho substituted to some degree.
The recent finding of PCB neurotoxicty
(37) with certain ortho but lightly substi-
tuted congeners may fall into this category.
Biochemical thyroid status at the cellular
level has been shown (38) to depend not
only on the concentration of free T4 but
also on the concentration of prealbumin.
Prealbumin is synthesized in the brain (as
well as the liver), where it plays a major
role in transport ofthyroid hormone to the
central nervous system (39).
Relationship to Retinoids
Another factor that may bear on some of
the toxicological properties ofPCBs relates
to evidence (40) suggesting a close associa-
tion between thyroid hormone and
retinoid transport, metabolism, and gene
transcription. For example, prealbumin
binds to retinol-binding protein, and this
serves as both a transport and protective
mechanism for the smaller protein (41).
Earlier findings (42) ofprealbumin deple-
tion in rat sera of dioxin-treated animals
coupled with findings (McKinneyJD et al.
unpublished observations) of a parallel
increase in retinol-binding protein and
retinol are consistent with this view and
further support a role for thyroid-hor-
mone-binding proteins in the mechanism
oftoxicity ofthese compounds. SAR stud-
ies (43) on the effects ofPCBs on retinoid
concentrations in serum and tissues indi-
cate that there are at least two classes of
PCBs (i.e., the coplanar PCBs that affect
hepatic, renal, and serum retinoids and
other ortho-substituted PCBs that only
decrease serum retinol). It is not clear
whether these effects are secondary to the
effects of PCBs on thyroid hormone
metabolism. These effects may also reflect
differences in preferences for the two class-
es of thyroid-hormone-binding proteins
described earlier.
Relationship to Estradiol
Another class of hydroxylated PCBs (pre-
sumed metabolites) have been shown (22)
to bind specifically to the mouse uterine
estrogen receptor and as such represent
potential agonists/antagonists ligands for
certain estrogen receptor functions. As
described earlier, this is believed to be asso-
ciated with a close match of the phenolic
ring with the A-ring in estradiol and
enhanced steroidlike structure brought
about by the ortho substituents. Develop-
mental and reproductive toxicity are possi-
ble outcomes of interactions of this type
with steroid hormone receptors. For exam-
ple, reproductive impairment in marine
mammals has been directly attributed to
feeding on PCB-contaminated fish (44).
The potential human health effects of
exposure to ortho-substituted PCBs and
their hydroxylated metabolites should be
considered in this light.
Conclusions
From a structural chemistry point ofview,
there are at least two distinct classes of
PCBs: the non-ortho- and ortho-substituted
congeners. The important distinguishing
feature of the non-ortho-substituted PCBs
is the energetic accessibility ofthe coplanar
state that can facilitate stacking interac-
tions such as may occur in a receptor-bind-
ing domain. The effects of ortho substitu-
tion on PCB reactivity are less clear, but
they can include three basic types: hin-
drance to stacking interactions, conforma-
tional restriction and more rigid steroidlike
structure, and increased carbon-chlorine
bond polarizability in nonlateral positions.
Lateral chlorine substituents can be impor-
tant in enhancing the binding properties of
both classes ofPCBs through polarizability
interactions.
For the non-ortho-substituted (copla-
nar) congeners, most, if not all, of the
important toxic effects we know about
appear to be mediated by binding to the
dioxin or Ah receptor. A simple stacking
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interaction model involving planar faces is
offered as a way to visualize the Ah-recep-
tor-binding process, but it must be viewed
as an oversimplication of a complex bind-
ing interaction. Further support for the
stacking model is derived from analysis of
the important structural features of the
more active dioxinlike chlorinated
diphenyl ethers. The activity ofthe chlori-
nated diphenyl ethers also provides support
for the thyromimetic properties of these
classes of compounds. The prealbumin
interaction model is offered as a way to
visualize the requirement for lateral sub-
stituents in cleft-type binding interactions.
The estrogen active analog modeling
approach offers one way of understanding
the importance of ortho substituents and
conformational restriction in receptor
binding. For the ortho- substituted con-
geners, the link to specific toxic endpoints
are not well established, and it is likely that
multiple mechanisms are involved. To
some extent, quantitative differences in
responses appear to be due to variations in
the degree ofcoplanarity or conformation-
al restriction (both dependent on degrees
oforthosubstitution) or accessibility ofpla-
nar faces and laterality that exists among
the PCB congeners. Agonist and antago-
nist effects may also depend on variations
and combinations ofthe important reactiv-
ity properties (kinds and amount) among
the congeners. There appear to be some
areas of overlap between the two PCB
classes such as the weak dioxinlike proper-
ties of certain mono-ortho-substituted
PCBs, but the significance of this is not
fully understood. As ortho substitution in
biphenyls is expected to lower their dioxin-
like binding properties in biological sys-
tems, one might anticipate differences in
their toxicokinetic properties based on the
degree ofortho substitution (45).
As suggested earlier, PCBs may inter-
fere with endocrine function in various
ways. Their ability to directly mimic natur-
al hormones (both as potentially potent
and persistent agonists and antagonists)
including recognition of their specific
binding sites is emerging as a guiding con-
cept in the case of the thyroid and estro-
genic steroid hormones. Indirect effects
might include alterations in the receptor
number or affinity of other hormones
involved in multihormonal regulating sys-
tems. For example, there is evidence (46)
for a direct effect of thyroid hormone on
the hepatic synthesis ofestrogen receptors.
The antiestrogenic action of dioxin (4/)
and possibly coplanar PCBs (48) in down-
regulating estrogen receptors could be
related to their potential thyromimetic
properties. Toxicity could result from over-
or underexpression of normal hormonal
responses that may be mediated by both
receptor and nonreceptor protein and asso-
ciated DNA interactions. For example,
recent work (49P) suggests that the human
estrogen receptor structural gene contains a
DNA sequence that binds activated mouse
and human Ah receptor.
The potential for reproductive and
developmental toxicity (50) is ofparticular
concern. Thyroid hormones are known to
be essential for brain development (51),
and many investigators (52) have provided
evidence demonstrating effects of hor-
mones on immature brain cell maturation,
myelinogenesis, protein and nucleic acid
metabolism, and electrical activity of the
growing brain. In addition, there are a
number of well-documented examples of
the regulation of single and multiple clus-
ters of genes through multiple hormonal
interactions (53). Thyroidal, adrenal, and
gonadal hormones are all necessary for the
normal differentiation of the nervous sys-
tem and involved in the ultimate expres-
sion of the target genes in several of these
multihormonal regulating systems. Because
humans are exposed to mixtures of PCB
congeners, it is likely that there are com-
plex interactive biological effects.
Understanding the biological properties of
PCBs and how they are determined by the
molecular structure are important research
objectives. Perhaps more direct molecular
biological approaches would be helpful in
elucidating the involvement ofboth recep-
tor and nonreceptor protein-mediated
responses. In turn, such mechanistic
insight should be helpful in reducing the
scientific uncertainty associated with
health hazard/risk assessments associated
with human exposures to PCBs and related
compounds.
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